Accessibility Menu

Quest PharmaTech(TSXV) QPT

Market CapCA$3.38MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1999)-98%
5 Year-76%
1 Year-50%
1 Month-20%
CA$0.02
+0.00%
+0.00Today
Quest PharmaTech last closing stock price
MetricPriceDate
Last closeCAD 0.022026-08-27
Quest PharmaTech stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%CAD 0.022026-08-20
1 month-20%CAD 0.032026-07-24
3 month-33.33%CAD 0.032026-05-29
Year to date-42.86%CAD 0.042025-12-30
1 year-50%CAD 0.042025-08-27
3 year-71.43%CAD 0.072023-08-25
5 year-76.47%CAD 0.092021-08-27
Since inception-97.78%CAD 0.901999-03-30

Quest PharmaTech Financials at a Glance

Market Cap

CA$3.38MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$0.00

Net Income (TTM)

CA$5.00

EPS (TTM)

CA$0.03

P/E Ratio

0.68

Dividend

CA$0.00

Beta (Volatility)

0.39 (Low)

Price

CA$0.02

Volume

10,000

Open

CA$0.02

Previous Close

CA$0.02

Daily Range

CA$0.02 - CA$0.02

52-Week Range

CA$0.02 - CA$0.05

Estimated Earnings Date

N/A

QPT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Quest PharmaTech

Quest PharmaTech, Inc. is a biotechnology company, which develops and commercializes antibody based immunotherapeutic products for cancer. It focuses on developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications. The firm is developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target, truncated O-glycans on MUC16. The company was founded in 1996 and is headquartered in Edmonton, Canada.

Industry

Biotechnology

Sector

Health Care

CEO

Ragupathy G. Madiyalakan, PhD

Website

www.questpharmatech.com

QPT Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

20.90%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

1.47%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

CA$3.38MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

169.13M

Volume

10.00K

Avg. Volume

38.55K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Quest PharmaTech Performance Analysis

Quest PharmaTech annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-01-31CAD 0N/A
20242024-01-31CAD 0N/A
20252025-01-31CAD 0N/A
20262026-01-31CAD 0N/A
Quest PharmaTech annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-01-31CAD -0.04-91.4%
20242024-01-31CAD -0.02-59.1%
20252025-01-31CAD -0.01-40.4%
20262026-01-31CAD 0.03N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

CA$0.00

N/A

Gross Profit

CA$0.00

N/A

Gross Margin

N/A

N/A

Market Cap

CA$3.38MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

CA$3.40

-2.0%

EBITDA

-CA$0.20

+0.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

CA$1.01

-15.8%

Total Debt

CA$1.00

+1.0%

Accounts Receivable

N/A

N/A

Inventory

CA$0.00

N/A

Long Term Debt

CA$0.00

N/A

Short Term Debt

CA$1.00

+1.0%

Return on Assets

19.87%

-2.6%

Return on Invested Capital

-3.18%

-0.5%

Free Cash Flow

-CA$0.04

-2.3%

Operating Cash Flow

-CA$0.04

-2.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About QPT

What is the current price of Quest PharmaTech?

Quest PharmaTech is trading at CA$0.02 per share.

What is the 52-week range for Quest PharmaTech?

Over the past 52 weeks, Quest PharmaTech has traded between CA$0.02 and CA$0.05.

How much debt does Quest PharmaTech have?

As of the most recent reporting period, Quest PharmaTech reported total debt of CA$1.00M.

How much cash does Quest PharmaTech have on hand?

Quest PharmaTech reported CA$14.36K in cash and cash equivalents in its most recent financial results.

What is Quest PharmaTech’s dividend yield?

Quest PharmaTech does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services